A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

The Ensign Group Acquires 3 Skilled Nursing Facilities in Colorado

April 6, 2021

The Ensign Group, Inc., the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational, and speech therapies, and other rehabilitative and healthcare services, announced today that it acquired the operations of the following skilled nursing facilities in Colorado:

These acquisitions were effective April 1, 2021, and will be subject to a long-term, triple net lease.

“We are pleased to be adding these operations to our Colorado portfolio and look forward to the contribution they will make to our same-store operations in the state,” said Barry Port, Ensign’s Chief Executive Officer.

Dave Jorgensen, President of Endura Healthcare, Inc., Ensign’s Colorado-based subsidiary, added, “Each of these operations is well situated to become the operation-of-choice in their markets. We are excited to work together with our healthcare partners as we strive to provide top-notch care for our patients and their families.”

This acquisition brings Ensign’s growing portfolio to 235 healthcare operations, 22 of which also include assisted living operations, across thirteen states. Ensign owns 94 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, assisted living, and other healthcare-related businesses throughout the United States.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy